Accelerating drug development, regulatory success, and scientific excellence across the pharmaceutical lifecycle.
The pharmaceutical industry is at the forefront of scientific innovation, transforming healthcare through the development of life-saving drugs, vaccines, and therapies. Navigating this highly regulated landscape requires expertise in clinical research, regulatory compliance, medical writing, and post-market surveillance to ensure that products are safe, effective, and meet global standards.
To help meet these challenges, Pubrica provides a range of services to the pharmaceutical industry, across research and discovery, marketing materials, and regulatory compliance. These services aim to be able to help in all facets of pharmaceutical drug development from discovery to market and clinician adoption. This comprehensive approach supports the scientific rigor of pharmaceutical development and enhances the marketability of solutions that can have a significant impact on global health. Our pharmacologists, researchers, and marketing experts collaborate to support every stage of pharmaceutical development.
The pharmaceutical industry is a dynamic and highly regulated sector where precision, safety, and compliance are paramount. At Pubrica, we provide comprehensive solutions that support every stage of the pharmaceutical product lifecycle. From research and development to regulatory submissions and post-market management, our services are designed to ensure your products meet global standards while optimizing efficiency and patient safety.
End-to-end pharmacovigilance services, including adverse event reporting, risk management, and ongoing safety surveillance to ensure patient safety and regulatory compliance.
Ensuring adherence to Good Manufacturing Practices (GMP), Good Clinical Practices (GCP), and other global quality standards.
Preparation of clinical study reports, research manuscripts, and regulatory documents with precision and clarity.
Comprehensive support in preparing CTD dossiers, IND/NDA submissions, and regulatory documentation in line with global standards (FDA, EMA, ICH).
End-to-end support for clinical trials, from study design and protocol development to data analysis and reporting.
Strategic support for product launch, post-marketing surveillance, and ongoing compliance throughout the product lifecycle.
At Pubrica, we provide specialized support across a broad range of pharmaceutical segments, catering to diverse therapeutic areas and product types. Our expertise ensures compliance, efficiency, and scientific rigor at every stage of the product lifecycle.
Small molecules, biologics, and advanced therapies require rigorous regulatory and clinical support.
Support for regulatory submissions, bioequivalence studies, and market entry strategies.
Guidance on regulatory compliance, labelling, and safety monitoring.
Expertise in clinical trials, pharmacovigilance, and regulatory dossier preparation.
Orphan drugs, oncology treatments, and niche therapeutics with complex development pathways.
Regulatory guidance, quality assurance, and safety documentation.
Support in quality control, regulatory filings, and compliance documentation.
Stages in the Drug Development Process:
The discovery phase of drug development is an early, critical part of the process where potential drug targets are identified and validated to select the most promising candidate for advancement.
The drug discovery and development process is long, challenging, and rewarding at the same time. New medicines save lives and improve the quality of life for millions of people. The development of prescription and over-the-counter drugs, vaccines, cell therapies, medical devices, and surgical or other treatment procedures can stop diseases from getting worse or even reverse their course. However, it often takes 10-15 years and can cost billions of dollars to bring a new treatment or therapy to market.
The process begins with the identification of a new target molecule, a protein or other molecule involved in the disease process. Once a target molecule is identified, scientists must design and synthesize a new compound that will interact with the target molecule and influence or inhibit its function.
Target identification is the first step in the drug discovery process, where researchers identify specific molecular targets within the body that play key roles in a disease or condition. By understanding the underlying biological mechanisms and pathways associated with the disease, scientists can identify potential targets that can be modulated to achieve therapeutic effects. Target identification involves a combination of experimental and computational approaches, including genomic, proteomic, and bioinformatic analyses.
Our authors share Pubrica’s expert content in top-tier journals, conferences, and platforms, maximizing and amplifying its recognition and reach. Our placement will enhance our visibility and elevate our standing in an authoritative capacity.
Paper Title: Novel Approaches in the Drug Development and Delivery Systems for Age-Related Macular Degeneration
Author: Paliwal, H., Prajapati, B. G., Srichana, T., Singh, S., & Patel, R. J.
Journal Name: Life (Basel, Switzerland)
Publisher: MDPI
Impact factor: 3.4
Pubrica’s team of industry specialists offers unrivalled expertise and perspectives to provide complete solutions with precision and originality. Through a mix of both experience and specialization, they strive for excellence in everything they do.
PHD - Pharmaceutical Research
PHD - Pharmaceutical Research
PHD - Pharmaceutical Research
The team at Pubrica has been instrumental in navigating complex regulatory requirements. Their meticulous approach to dossier preparation and pharmacovigilance has ensured our products meet global standards efficiently.
— Dr. Rakesh Mehta
Director of Regulatory Affairs, SunPharma,
India
With Pubrica's support, our R&D initiatives have become more streamlined and effective. Their insights and technical expertise have significantly enhanced our drug development processes.
— Dr. Priya Nair
Head of Research & Development, Novartis,
Switzerland
From development to post-market surveillance, Pubrica has been a reliable partner. Their comprehensive services have allowed us to focus on innovation while maintaining compliance and quality.
— Dr. Neha Verma
Clinical Operations Lead, Roche,
Germany
Journals expect a clear structure for case reports and review articles, featuring precise objectives, rigorous timeline analysis..
Publishing a case report involves more than clinical knowledge; it also demands strategic journal targeting, matching visibility metrics..
Effective patient education materials (PEMs) are crucial for promoting health literacy, enhancing compliance, and bridging care delivery gaps..